Back to search

Article

Repurposing Live Attenuated Trivalent MMR Vaccine as Cost-effective Cancer Immunotherapy

2022-03-01

Abstract excerpt

<h4>ABSTRACT</h4> Despite its rising promise, cancer immunotherapy remains out of reach for many patients because of the extensive cost of manufacturing immunotherapy products. In this study, we show that intratumoral injections of the trivalent measles, mumps, and rubella (MMR) live attenuated viral vaccine (LAVs) modulates a potent cytotoxic T-cell antitumor immune response, resulting in tumor growth inhibition...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c22c5717-35fb-579b-8c50-805b6030d333
DOI
10.1101/2022.02.25.481685
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Repurposing Live Attenuated Trivalent MMR Vaccine as Cost-effective Cancer ImmunotherapyDOI 10.1101/2022.02.25.481685
Select a neighboring publication to make it the new centre.